Latin America Medical Cannabis Market, by Route of Administration

Growth Outlook

• The Latin America Medical Cannabis Market, by Route of Administration market is on a steady long-term growth path. Segment value stands at roughly USD 346 Mn in 2026 and is projected to reach USD 403 Mn by 2027 — a gain of about 17% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Inhalation leads, holding roughly 58% of segment value — the single largest regional share. Oral is the second-largest contributor. Topical make up the remainder, in descending order.
• By 2027, Inhalation alone is expected to reach USD 235 Mn, with Oral at USD 110 Mn.

Market Dynamics

Latin America is quickly becoming a major player in the global medical cannabis market. With a population of over 650 million people and a growing demand for alternative medical treatments, the region is poised for significant growth in the coming years.

One of the key factors driving the demand for medical cannabis in Latin America is the increasing acceptance and legalization of the plant for medical purposes. While cannabis remains illegal for recreational use in most countries in the region, many have passed legislation allowing for its use in treating various medical conditions. For example, in 2019, Argentina became the first country in Latin America to legalize medical cannabis, followed by Peru in 2020. Other countries such as Colombia, Uruguay, and Mexico have also made strides in legalizing and regulating medical cannabis.

The demand for medical cannabis is also being driven by the growing awareness and acceptance of the potential benefits of the plant for various medical conditions. Cannabis has been found to be effective in treating a range of conditions such as chronic pain, epilepsy, multiple sclerosis, and PTSD, among others. As more research is conducted on the potential health benefits of cannabis, the demand for medical cannabis is expected to continue to rise in Latin America.

When it comes to the route of administration, there are several options available for medical cannabis consumption in Latin America. These include inhalation, oral ingestion, sublingual/buccal, and topical applications. Each of these methods has its own benefits and drawbacks, and the choice of administration route may vary depending on the patient's condition and preferences.

Inhalation, through smoking or vaporization, is one of the most common routes of administration for medical cannabis. This method allows for quick absorption of the cannabinoids into the bloodstream, providing fast relief for symptoms. However, there are concerns about the potential risks of respiratory irritation from smoking.

Oral ingestion, in the form of oils, capsules, or edibles, is another popular route of administration in Latin America. This method offers a longer-lasting effect compared to inhalation, but the onset of action may be slower as the cannabinoids have to pass through the digestive system.

Sublingual and buccal administration involves placing cannabis products under the tongue or in the cheeks for rapid absorption into the bloodstream. This method allows for a faster onset of effects than oral ingestion, but it may not be suitable for all patients.

Lastly, topical applications, such as creams and oils, are becoming increasingly popular for localized pain relief and skin conditions. This route of administration allows for targeted relief without the psychoactive effects of ingested or inhaled cannabis.

In conclusion, the demand for medical cannabis in Latin America is on the rise, with a growing number of countries legalizing its use for medical purposes. The choice of route of administration may vary depending on the patient's condition and preferences. As the region continues to embrace medical cannabis, we can expect to see further developments and advancements in its use and administration.